Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
about
Therapies for Prevention and Treatment of Alzheimer's DiseaseEndocrine Risk Factors for Cognitive ImpairmentRole of Pro-Inflammatory Cytokines and Vitamin D in Probable Alzheimer's Disease with Depression.Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer's disease.Metabolic profiling distinguishes three subtypes of Alzheimer's disease.The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients.Aptamer and its applications in neurodegenerative diseases.Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease.Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's diseaseAssociation of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.Adipose-brain crosstalk: do adipokines have a role in neuroprotection?The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity.Leptin Regulation of Synaptic Function at Hippocampal TA-CA1 and SC-CA1 Synapses: Implications for Health and Disease.Cerebrovascular Disease: Consequences of Obesity-Induced Endothelial Dysfunction.Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.
P2860
Q26740007-AB34CE01-D8D5-4607-AEE9-2DB3963DC89DQ26749493-EB4A61AF-5ABE-40D1-904D-129C1B808ED4Q33714240-85C216EB-5A84-4F73-BC31-9103D391E26EQ33819563-8AD89347-0D56-4B56-8A9F-84CFA3D9B54BQ36100673-B18A4F2A-FE93-46E2-ABDE-5C2598F55A76Q38809233-D3A3A251-84DA-4191-A03A-34F7799CBDAAQ38830118-8FF7B1AE-C6CF-4492-A50C-9FBA65B46494Q38937721-D1C7DFDF-1FF8-40E3-869E-8DB1A312DFB2Q39151408-CC7AAA6E-8190-4E0C-BCD4-EB02914FE3FCQ39205712-8C8109CD-F40D-44AD-9943-8A3B178CC6F2Q41039610-0025F10A-21FB-4D09-A812-92D5D4BD14D2Q41846067-4C87F430-7025-4638-B722-D00134BDC037Q47586109-1ACDC4CF-A53F-4E77-8DDC-DBAC53B5EDEAQ48218464-B2DEE4A6-1FFD-4F1D-B0B7-51E72A8F3549Q49970492-25E48DAF-297B-48B9-977F-6EFC7156B5E6Q50190372-051C52AC-9A51-4723-B7EF-2E6EF8472126Q54977832-4E4A11B6-DA7C-4C8D-829C-6D9E9043D19D
P2860
Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@ast
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@en
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@nl
type
label
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@ast
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@en
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@nl
prefLabel
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@ast
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@en
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Metabolic Risk Factors of Spor ...... gy, Pathogenesis and Treatment
@en
P2093
Anindita Banerjee
Anirban Ganguly
Atanu Biswas
Gargi Chatterjee
Sasanka Chakrabarti
P2860
P304
P3181
P356
10.14336/AD.2014.002
P407
P577
2015-08-01T00:00:00Z